Paris threatens millions in penalties if paracetamol-maker leaves France after US takeover
The deal has faced intense, cross-party scrutiny in Paris.
Sanofi
France to take stake in Sanofi unit to quell backlash over sale to US firm
Move follows fears over jobs and control when private equity firm CD&R entered talks to buy Opella for €16bnThe French government is to take a stake in the pharmaceutical company Sanofi’s consumer healthcare division to try to quell a backlash as t…
Sanofi pursues sale of France’s leading painkiller to US investment fund after controversy
French pharmaceutical company Sanofi confirmed on Monday its plans to sell a controlling stake in its consumer health unit Opella to a US investment fund, after providing the French government with guarantees on maintaining jobs and production within …
French state takes stake in Sanofi unit in bid to allay backlash
Deal for consumer health arm faced political furore over ceding controlling stake to American private equity group
Paris backs €15B sale of paracetamol-maker to US fund after winning guarantees
French public investment bank to buy shares in Sanofi subsidiary amid American takeover.
France warns it could block €15.5bn Sanofi consumer health deal
Proposed sale of controlling stake to US private equity group has sparked backlash in country
Bloquer le rachat du Doliprane ? “Pas justifié” pour l’instant, selon une note de Bercy
Pressé de toutes parts pour empêcher le passage d’une filiale de Sanofi sous pavillon américain, l’exécutif avance avec une extrême prudence.
Paris seeks to calm Sanofi workers’ fears over American takeover
French government threatens sanctions if production leaves France; downplays vetoing the deal.
French politicians alarmed by sale of major consumer healthcare firm to US equity firm
Sanofi sale highlights concerns over EU’s ability to produce basic medicines.
Who’s the real health commissioner?
SNEAK PEEK — EU health policy is now split across multiple departments, and MEPs aren’t happy. — Sort your own house out first: MEPs question Hungarian health secretary over presidency plans and country’s health commissioner role. — Spend less on defense and more on health, WHO chief Tedros told world leaders at the United Nations […]
Solid science in Europe: a farewell song?
Maintaining the highest standards is the only avenue to strengthen the EU health sector.
Type 1 Diabetes can be fast, but we can be faster! A call to boost early detection [Promoted content]
The European Diabetes Forum (EUDF), the International Diabetes Federation (IDF) Europe, the Spanish Diabetes Federation (FEDE), the Parliamentarians for Diabetes Global Network (PDGN) and Sanofi co-organised the Early Detection Policy Forum to accelera…
It’s time to address this leading cause of death: COPD
A new report about the global state of COPD offers insights from 30 national experts on how policy action can be implemented worldwide.
Spéciale Aix : brouillard sous le soleil
Notre newsletter quotidienne sur les enjeux de lobbying et de transparence en France. Par PAUL DE VILLEPIN Avec OCÉANE HERRERO, JASON WIELS ET MARION SOLLETTY Infos, tuyaux et mini-drames à partager ? Ecrivez à Océane Herrero, Paul de Villepin et Judith Chetrit | Voir dans votre navigateur LE MENU DU JOUR — Relevé de température aixoise […]
Health fund of $1.1 bn announced in Paris to support vaccines production in Africa
The release of over a billion dollars to accelerate vaccine production in Africa has been announced at the Global Forum on Vaccine Innovation and Sovereignty taking place in Paris on Thursday (June 20).
Sanofi calls for next Commission to boost Europe’s research capabilities [Advocacy Lab Content]
Sanofi is emphasising the strategic importance of Belgium in its pharmaceutical research and development initiatives, while also highlighting the EU’s potential to lead an artificial intelligence-driven revolution in medicine, particularly in medicines…